| Structure |
Chemical Name |
CAS |
MF |
 |
PANTOPRAZOLE N-OXIDE |
953787-60-5 |
C16H15F2N3O5S |
 |
SalMeterol IMpurity D |
|
C25H37NO4 |
 |
Ticagrelor impurity PDD |
|
|
 |
Cephalexin IMpurity J |
|
C16H17N3O4S |
 |
Dapoxetine impurity 63 |
|
|
 |
(6α)-17,21-Dihydroxy-6-Methylpregna-1,4,9(11)-triene-3,20-dione |
93269-35-3 |
C22H28O4 |
 |
Sugammadex sodium Org246653-1 Impurity |
|
|
![2-(2-butyl-4-methyl-1-((2'-(1-methyl-
1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-
yl)methyl)-6-oxo-1,6-
dihydropyrimidin-5-yl)-N,Ndimethylethanethioamide
2-(2-butyl-4-methyl-1-((2'-(2-methyl-
2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-
yl)methyl)-6-oxo-1,6-
dihydropyri](/) |
2-(2-butyl-4-methyl-1-((2'-(1-methyl-
1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-
yl)methyl)-6-oxo-1,6-
dihydropyrimidin-5-yl)-N,Ndimethylethanethioamide
2-(2-butyl-4-methyl-1-((2'-(2-methyl-
2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-
yl)methyl)-6-oxo-1,6-
dihydropyri |
|
|
 |
Lumateperone Impurity 6 |
313368-82-0 |
C23H26FN3O |
 |
4-(4-(3-(4-chloro-3-(trifluoroMethyl)phenyl)ureido)-3-fluorophenoxy)-2-(MethylcarbaMoyl)pyridine 1-oxide |
835621-11-9 |
C21H15ClF4N4O4 |
 |
Pitavastatin Impurity 98 |
|
|
 |
nicergoline impurity E |
|
|
![ボセンタン関連化合物B (4-(TERT-ブチル)-N-[6-ヒドロキシ-5-(2-メトキシフェノキシ)-(2,2'-ビピリミジン)-4-イル]ベンゼンスルホンアミド)](/CAS/20150408/GIF/174227-14-6.gif) |
ボセンタン関連化合物B (4-(TERT-ブチル)-N-[6-ヒドロキシ-5-(2-メトキシフェノキシ)-(2,2'-ビピリミジン)-4-イル]ベンゼンスルホンアミド) |
174227-14-6 |
C25H25N5O5S |
 |
ethyl 2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-
carboxylate |
2230270-05-8 |
C18H20N2O3S |
 |
Ticagrelor Related Compound 5 |
1414348-35-8 |
C9H9F2N |
 |
2-((4-(カルボキシメチル)フェノキシ)メチル)安息香酸 |
55453-89-9 |
C16H14O5 |
![IMp. B (EP): (2RS,4S)-2-[[[[3-(2-Chloro-6-fluorophenyl)-5-Methylisoxazol-4-yl]carbonyl]aMino]Methyl]-5,5-diMethyl- thiazolidine-4-carboxylic Acid (Penilloic Acids of Flucloxacillin)](/) |
IMp. B (EP): (2RS,4S)-2-[[[[3-(2-Chloro-6-fluorophenyl)-5-Methylisoxazol-4-yl]carbonyl]aMino]Methyl]-5,5-diMethyl- thiazolidine-4-carboxylic Acid (Penilloic Acids of Flucloxacillin) |
|
|
 |
Levofloxacin Impurity 20 |
2489671-29-4 |
C18H20FN3O4 |
 |
LincoMycin iMpurity C |
|
|
 |
Azilsartan Medoxomil Potassium impurity209 |
|
|
 |
Cephalosporin Impurity 3 HCl |
2429-86-9 |
C14H17N3O6S |
 |
Bis(4-fluorobenzyl)aMine |
646051-52-7 |
C14H13F2N |
 |
BenzaMide, 3,4-bis(cyclopropylMethoxy)-N-(3,5-dichloro-4-pyridinyl)- |
1391052-24-6 |
C20H20Cl2N2O3 |
 |
LAT-NET |
607351-44-0 |
C25H39NO4 |
 |
(3S,5R)-Fluvastatin SodiuM Salt |
94061-81-1 |
C24H25FNNaO4 |
 |
5-(1-amino-2-(methylsulfonyl)ethyl)-2-methoxyphenol |
2169153-70-0 |
C10H15NO4S |
 |
4-((5,6-dimethoxy-1H-inden-2-yl)methyl)piperidine |
1026443-48-0 |
C17H23NO2 |
 |
D-erythro-3,4-Dihydroxyphenylserine |
51829-98-2 |
C9H11NO5 |
 |
(S)-N-(1-(3-MethylbutanaMido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
862894-96-0 |
C19H22N4O3 |
 |
ethyl 2-(4-(sec-butoxy)-3-cyanophenyl)-4-methylthiazole-5-
carboxylate |
2375033-35-3 |
C18H20N2O3S |
 |
Silodosin Impurity 6 |
|
|
 |
Ticagrelor Impurity 113 |
|
|
 |
Hydroxytyrosol 4-O-glucoside |
54695-80-6 |
C14H20O8 |
 |
Methyl 3-aMino-2-((2'-carbaMoylbiphenyl-4-yl)MethylaMino)benzoate |
147404-75-9 |
C22H21N3O3 |
 |
IMp. A (EP): (RS)-2-Chloro-N-(2-Methylphenyl)-PropanaMide |
39084-88-3 |
C10H11Cl2NO |
 |
Canagliflozin Impurity 49 |
2243132-56-9 |
C34H35FO11S |
 |
7-Hydroxy Alosetron |
863485-44-3 |
C17H18N4O2 |
 |
Tofacitinib Impurity 100 |
|
|
 |
(1r,4r)-4-((2-amino-4-bromobenzyl)amino)cyclohexan-1-ol hydrochloride |
|
C13H20BrClN2O |
 |
Pregna-1,4,9(11)-triene-3,20-dione,21-(acetyloxy)-17-hydroxy-6-methyl-, (6a)- |
93239-37-3 |
C24H30O5 |
 |
OEM Honey |
|
|
 |
Irbesartan IMpurity |
1079997-01-5 |
C26H30N6O2 |
 |
Valaciclovir EP Impurity O |
|
|
 |
1,8-bis(4-((1,4,8,11-tetraazacyclotetradecan-4,8,11-trifluoroacetyl- 1-yl)methyl)benzyl)-4,11-difluoroacetyl-1,4,8,11- tetraazacyclotetradecane |
|
|
 |
Imatinib impurity XT |
|
|
 |
O-Desethyl Candesartan Cilexetil |
869631-11-8 |
C31H30N6O6 |
 |
Cefdinir Impurity IJKL |
|
|
 |
Hexanoic acid, 3-(hydroxymethyl)-, (3R)- |
2096999-79-8 |
C7H14O3 |
 |
4-amino-5-chloro-N-(1-propylpiperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
|
C17H24ClN3O2 |
 |
エピピノレシノール-4-O-β-D-グルコシド |
24404-49-7 |
C26H32O11 |
 |
Ticagrelor Related Compound 73 |
|
|
 |
beta-D-Hydroxymethoxymethylanthraquinonyl glucopyranoside |
29013-18-1 |
C22H22O10 |
 |
Avatrombopag Impurity 60 |
|
|
 |
Azacitidine Impurity 37 |
206269-46-7 |
C8H12N4O5 |
 |
2-(3-formyl-4-isobutoxyphenyl)-N,N,4-trimethylthiazole- 5-carboxamide |
1380049-42-2 |
C18H22N2O3S |
 |
(4S,4aR,5R,12aS)-4-(dimethylamino)-3,5,10,11,12a-pentahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide |
4660-26-8 |
C22H22N2O8 |
 |
Etoposide Impurity 4 |
101648-60-6 |
C35H32Cl6O16 |
![1,1-dimethyl-4-(2-methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-ium iodide](/CAS/20180703/GIF/CB83146796.gif) |
1,1-dimethyl-4-(2-methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-ium iodide |
|
C18H23IN4S |
 |
Oseltamivir Impurity 91 |
|
|
 |
(S)-dimethyl 2-(4-(4-oxobutyl)benzamido)pentanedioate |
1081974-98-2 |
C18H23NO6 |
 |
7-methyl-3,4-dihydropyrimido |
|
|
 |
Canagliflozin Impurity 17 |
1951467-28-9 |
C24H23FO6S |
![2-[(4-Chloro-3-Methyl-2-Pyridinyl-methyl)thio]-1H-Benzimidazole](/CAS/GIF/103312-62-5.gif) |
2-[(4-Chloro-3-Methyl-2-Pyridinyl-methyl)thio]-1H-Benzimidazole |
103312-62-5 |
C14H12ClN3S |
 |
Prednicarbate Impurity D |
|
|
 |
AMpicillin EP IMpurity E |
|
|
 |
Butyphthalide impurity 38 |
1841089-56-2 |
C24H30O5 |
 |
4'-ヒドロキシアセトフェノンオキシム |
34523-34-7 |
C8H9NO2 |
 |
(trans)-4-((2-amino-3,6-dibromobenzyl)amino)cyclohexanol |
|
C13H18Br2N2O |
 |
1,3,7-トリメチル-8-クロロキサンチン |
4921-49-7 |
C8H9ClN4O2 |
 |
N-Ethoxycarbonyl Ciprofloxacin |
93594-29-7 |
C20H22FN3O5 |
 |
IBrutinib Impurity C |
|
|
 |
2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-N-(5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-1H-indazol-3-yl)benzamide |
|
|
 |
edaravone iMpurity |
1942007-91-1 |
C13H14N2O3S |
 |
1-イソプロピル-3-(4-フルオロフェニル)-1H-インドール-2-カルボアルデヒド |
101125-34-2 |
C18H16FNO |
 |
Etoricoxib Impurity 41 |
855307-80-1 |
C18H13ClN2O2S |
 |
IMidafenacin IMpurity (1-(3-Cyano-3,3-Diphenylpropyl)-2-Methyl-1H-IMidazoliuM Phosphate) |
562091-56-9 |
C20H22N3O4P |
 |
Lincomycin sulfoxide Impurity 6 |
|
|
 |
Afatinib Impurity 23 |
1314777-66-6 |
C8H4FN3O3 |
 |
Pramipexole Impurity W |
|
|
![2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)-](/CAS/20200611/GIF/1564265-94-6.gif) |
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)- |
1564265-94-6 |
C18H25N3O2 |
 |
Febuxostat Impurity 78 |
|
|
 |
Amlodipine EP Impurity K |
|
C26H31ClN2O8S |
 |
Rocuronium Bromide Impurity 26 、27 |
|
|
 |
Leosimendan azide Impurity |
|
|
 |
methyl 3-(4-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)-3- oxopropanoate hydrochloride |
|
C16H24ClNO5 |
 |
γ-Cyclodextrin, 6A,6B,6C,6D,6E,6F,6G-heptabromo-6A,6B,6C,6D,6E,6F,6G-heptadeoxy- |
2458187-21-6 |
C48H73Br7O33 |
 |
Bisoprolol EP Impurity Q |
1346604-00-9 |
C16H27NO4 |
![(5R,6S)-6-((R)-1-hydroxyethyl)-7-oxo-3-((S)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid 4,4-dioxide](/) |
(5R,6S)-6-((R)-1-hydroxyethyl)-7-oxo-3-((S)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid 4,4-dioxide |
|
|
 |
2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid 1-oxide |
2418591-42-9 |
C16H16N2O4S |
 |
Norepinephrine EP Impurity D |
1932110-67-2 |
C9H13NO3 |
 |
Faropenem Impurity AB |
|
|
 |
Furosemide Impurity 24 |
|
|
 |
Salbutamol Impurity 38 |
|
|
 |
(R)-6-(2-((1S,2S)-2,6-dimethyl-1,2,3,4-tetrahydronaphthalen-1-yl) ethyl)-5,6-dihydro-2H-pyran-2-one and (R)-6-(2-((R)-2,6-dimethyl- 5,6,7,8-tetrahydronaphthalen-1-yl)ethyl)-5,6-dihydro-2H-pyran-2-one |
|
|
 |
MiraBegron Impurity A |
|
|
 |
(9S)-9-アミノ-9-デオキソエリスロマイシン |
26116-56-3 |
C37H70N2O12 |
 |
Empagliflozin Impurity 42 |
|
|
 |
Rivaroxaban Impurity 35 |
|
|
![1-(3,5-Dihydroxyphenyl)-2-[(1,1-diMethylethyl)(phenylMethyl)aMino]ethanone HydrobroMide](/CAS/GIF/94109-61-2.gif) |
1-(3,5-Dihydroxyphenyl)-2-[(1,1-diMethylethyl)(phenylMethyl)aMino]ethanone HydrobroMide |
94109-61-2 |
C19H23NO3 |
 |
Aprepitant iMpurity 41 |
|
|